NCT05645354已完成不适用
SmokefreeSGM, A Text-based Smoking Cessation Feasibility Trial for Sexual and Gender Minority Groups
The University of Texas Health Science Center, Houston2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2022年11月10日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 100
- 试验地点
- 2
- 主要终点
- Feasibility as Assessed by Number of Participants Recruited for the Study
研究概览
简要总结
The purpose of this study is to test the feasibility and acceptability of Smokefree Sexual and Gender Minority (SGM), an SGM-tailored version of the SmokefreeTXT text messaging program
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Self-identify as an LGBTQ+ individual
- •Currently live in the United States
- •Have smoked at least 100 cigarettes in their lifetime, smoke every day, and smoke greater than or equal to 5 cigarettes a day
- •Are willing to quit smoking in the next 15 days
- •Have a cell phone number with an unlimited short message service (SMS) plan
- •Have a positive cotinine saliva test to indicate their smoking status
排除标准
- •Have a prepaid cell phone plan (pay-as-you-go plan)
- •Have a cell phone number that does not work and/or is registered to someone else
- •Have inadequate equipment/devices (i.e., webcam, speakers, mic) for participating in telehealth sessions via Microsoft Teams, Webex, or Zoom AND cannot meet in-person
- •Pregnant or breastfeeding persons (nicotine patches are not generally recommended to this groups since nicotine can affect fetal and neonatal brain development)
- •Contraindication for nicotine patches. Absolute contraindications include: severe eczema or serious skin conditions, allergy to nicotine patches, pregnancy, breastfeeding, heart attack in the past 2 months, ongoing angina, peptic ulcer disease, arrhythmia, or uncontrolled blood pressure. Potential contraindications include: stroke in the past 6 months, insulin therapy, and a current diagnosis of liver, kidney, or heart disease. Study participants reporting a potential contraindication will require approval from their primary care provider and/or other treating physician (e.g., psychiatrist) to use nicotine patches. If the request is denied or not returned in 2 weeks, potential study participants will be excluded from the study.
- •Current use of tobacco cessation medications
- •Enrollment in another smoking cessation study
- •Non-English speakers
结局指标
主要结局
Feasibility as Assessed by Number of Participants Recruited for the Study
时间窗: Baseline
Feasibility as Assessed by Number of Participants That Completed Month 1 Visit
时间窗: end of month 1
Feasibility as Assessed by Number of Participants That Completed Month 3 Visit
时间窗: end of month 3
Acceptability as Assessed by Number of Participants Who Completed Qualitative Interviews
时间窗: 6 months follow up
Feasibility as Assessed by Number of Participants That Completed Month 6 Visit
时间窗: end of month 6
次要结局
- Number of Participants That Quit Smoking(6 month follow up)
研究者
Irene Tami-Maury
Assistant Professor
The University of Texas Health Science Center, Houston
研究点 (2)
Loading locations...
相似试验
已完成
不适用
SmokefreeSGM, A Text-based Smoking Cessation Intervention for Sexual and Gender Minority GroupsSmoking CessationNCT05029362The University of Texas Health Science Center, Houston18
暂停
不适用
SmokefreeSGM Español Pilot, Beta Testing a Text-based Smoking Cessation Intervention for Sexual and Gender Minority(SGM) Groups Preferring Spanish LanguageSmoking CessationNCT06487806The University of Texas Health Science Center, Houston20
已完成
不适用
Smoking Cessation E-VisitSmokingNCT04316260Medical University of South Carolina51
Unknown
不适用
Smoking Cessation in the Surgical Pathway Before Major Lung SurgerySmoking CessationThoracic SurgeryNCT04190966University of Birmingham120
已完成
1 期
Smoking Cessation Intervention for Thoracic PatientsLung CancerNCT00580398Massachusetts General Hospital49